Bausch Health Companies Inc. Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
Bausch Health Companies Inc. (BHC) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $10.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2026-07-30
- Bausch Health Companies Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2026-06-30 was $10.00M, a 11.11% increase year-over-year.
- Bausch Health Companies Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2025-12-31 was $0.00.
- Bausch Health Companies Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2025-06-30 was $9.00M.
- Bausch Health Companies Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2025 was $9.00M, a 10.00% decline from fiscal 2024.
- Bausch Health Companies Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2024 was $10.00M, a 11.11% increase from fiscal 2023.
- Bausch Health Companies Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2023 was $9.00M, a 18.18% decline from fiscal 2022.
- Bausch Health Companies Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2022 was $11.00M, a 10.00% increase from fiscal 2021.
| Period end | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month as first filed | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10.00M 10-Q · filed 2026-07-30 | $10.00M 10-Q · filed 2026-07-30 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $9.00M derived: sum of 3 quarters · filed 2026-07-30 | $9.00M 10-K · filed 2026-02-19 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-10-30 | $9.00M derived: sum of 2 quarters · filed 2026-07-30 | $9.00M 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | $9.00M 10-Q · filed 2026-07-30 | $9.00M 10-Q · filed 2026-07-30 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.00M derived: sum of 2 quarters · filed 2026-02-19 | $10.00M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $10.00M 10-Q · filed 2025-10-30 | $10.00M 10-Q · filed 2025-10-30 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.00M derived: sum of 2 quarters · filed 2026-02-19 | $9.00M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $9.00M 10-Q · filed 2024-10-31 | $9.00M 10-Q · filed 2024-10-31 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $11.00M derived: sum of 2 quarters · filed 2025-02-20 | $11.00M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $11.00M 10-Q · filed 2023-11-02 | $11.00M 10-Q · filed 2023-11-02 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $10.00M derived: sum of 2 quarters · filed 2024-02-22 | $10.00M 10-K · filed 2024-02-22 | |||
| 2021-09-30 | $10.00M 10-Q · filed 2022-11-03 | $10.00M 10-Q · filed 2022-11-03 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $6.00M derived: sum of 2 quarters · filed 2023-02-23 | $6.00M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $6.00M 10-Q · filed 2021-11-02 | $6.00M 10-Q · filed 2021-11-02 | ||||
| 2019-12-31 | $5.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $13.00M derived: sum of 2 quarters · filed 2022-05-11 | $13.00M 8-K · filed 2022-05-11 | |||
| 2019-09-30 | $8.00M 10-Q · filed 2020-11-03 | $8.00M 10-Q · filed 2020-11-03 | ||||
| 2018-12-31 | $2.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $5.00M derived: sum of 2 quarters · filed 2021-05-04 | $11.00M derived: sum of 3 quarters · filed 2021-05-04 | $11.00M 8-K · filed 2021-05-04 | ||
| 2018-09-30 | $3.00M 10-Q · filed 2019-11-04 | $9.00M derived: sum of 2 quarters · filed 2019-11-04 | $9.00M 10-Q · filed 2019-11-04 | |||
| 2018-06-30 | $6.00M 10-Q · filed 2019-08-06 | $6.00M 10-Q · filed 2019-08-06 | ||||
| 2017-12-31 | $9.00M 10-K · filed 2020-02-19 | |||||
| 2016-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$100.00K derived: sum of 2 quarters · filed 2019-02-20 | $9.00M 10-K · filed 2019-02-20 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $9.10M 10-Q · filed 2016-11-09 | ||||
| 2016-06-30 | $9.10M 10-Q · filed 2016-08-09 | |||||
| 2015-12-31 | $1.00M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $6.90M derived: sum of 2 quarters · filed 2018-08-10 | $8.00M 8-K · filed 2018-08-10 | $8.50M 10-K · filed 2016-04-29 | ||
| 2015-09-30 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $7.00M 10-Q · filed 2016-11-09 | ||||
| 2015-06-30 | $1.10M 10-Q · filed 2016-08-09 | |||||
| 2014-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.00M 10-K · filed 2017-03-01 | $2.20M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $500.00K 10-Q · filed 2015-10-26 | |||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $2.10M 10-K · filed 2016-04-29 | $2.10M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $2.10M 10-Q · filed 2014-10-24 | $2.10M 10-Q · filed 2013-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |